Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOdyssean Inves. Regulatory News (OIT)

Share Price Information for Odyssean Inves. (OIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.50
Bid: 162.50
Ask: 164.00
Change: 0.50 (0.31%)
Spread: 1.50 (0.923%)
Open: 163.00
High: 163.00
Low: 162.00
Prev. Close: 162.00
OIT Live PriceLast checked at -
Odyssean Investment Trust is an Investment Trust

To achieve attractive total returns per share principally through capital growth over a longterm period through investment in companies predominantly in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DISCLOSURE UNDER RULE 2.10(C) OF THE TAKEOVER CODE

1 Mar 2023 07:00

RNS Number : 4177R
Nucleus Financial Platforms Limited
28 February 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

1 March 2023

 

Disclosure under Rule 2.10(c) of the Takeover Code in respect of the

RECOMMENDED CASH ACQUISITION

of

CURTIS BANKS GROUP PLC

by

NUCLEUS CLYDE ACQUISITION LIMITED(a newly formed company wholly-owned by Nucleus Financial Platforms Limited)

Update on irrevocable undertaking given by Odyssean Capital LLP

On 6 January 2023 the boards of directors of Nucleus Clyde Acquisition Limited ("Bidco"), a newly formed company wholly-owned by Nucleus Financial Platforms Limited ("Nucleus"), and Curtis Banks Group PLC ("Curtis Banks"), made an announcement pursuant to Rule 2.7 of the Takeover Code (the "2.7 Announcement") that they had reached agreement on the terms of a recommended cash acquisition by Bidco of the entire issued and to be issued share capital of Curtis Banks (the "Acquisition"), intended to be implemented by way of a court sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme"). A circular in relation to the Scheme (the "Scheme Document") was published on 31 January 2023.

On 27 February 2023, the requisite majority of Scheme Shareholders voted to approve the Scheme at the Court Meeting and the requisite majority of Curtis Banks Shareholders voted to pass the Resolution to implement the Scheme at the General Meeting.

As set out in Appendix 3 of the 2.7 Announcement and paragraph 9 of Part VI of the Scheme Document, Bidco had received an irrevocable undertaking to vote in favour (or procure the voting in favour, as applicable) of the Scheme at the Court Meeting and the Resolution to be proposed at the General Meeting (or in the event that the Acquisition is implemented by way of a Takeover Offer, to accept or procure the acceptance of such Takeover Offer) from Odyssean Capital LLP as portfolio manager of Odyssean Investment Trust plc ("Odyssean") in respect of an aggregate number of 5,130,000 Curtis Banks Shares, representing approximately 7.67% of the issued share capital of Curtis Banks as at the close of business on 27 January 2023 (being the last practicable date prior to the publication of the Scheme Document) (the "Odyssean Irrevocable Undertaking"). As described in the 2.7 Announcement and the Scheme Document, the Odyssean Irrevocable Undertaking does not contain any restriction on disposals of Curtis Banks Shares by Odyssean.

On 8 February 2023 Odyssean announced that it had sold, in aggregate, 2,630,000 Curtis Banks Shares (the "Previously Sold Shares"), reducing the total number of Curtis Banks Shares subject to the Odyssean Irrevocable Undertaking to 2,500,000.

On 28 February 2023, Odyssean announced that it had sold its remaining 2,500,000 Curtis Banks Shares (the "Sold Shares"). Odyssean has informed Bidco that the Sold Shares comprised Curtis Banks Shares that were subject to the Odyssean Irrevocable Undertaking.

As a result, following completion of the sale of the Sold Shares:

· the total number of Curtis Banks Shares which are subject to the Odyssean Irrevocable Undertaking has reduced to zero Curtis Banks Shares; and

 

· the total number of Curtis Banks Shares which are subject to irrevocable undertakings or letters of intent received by Bidco from Curtis Banks Shareholders has reduced to 30,958,109 Curtis Banks Shares, representing approximately 46.29% of the issued share capital of Curtis Banks as at the close of business on 28 February 2023 (being the date prior to this announcement).

Unless otherwise defined in this announcement, capitalised words and phrases used in this announcement shall have the same meanings given to them in the 2.7 Announcement.

Enquiries

 

Evercore (financial adviser to Nucleus and Bidco)

+44 (0)20 7653 6000

Ollie Clayton

 

Ed Banks

 

Demetris Efthymiou

 

Harrison George

 

 

 

TB Cardew (public relations adviser to Nucleus and Bidco)

 

Tom Allison

+44 (0)77 8999 8020

Shan Shan Willenbrock

+44 (0)77 7584 8537

Olivia Rosser

+44 (0)7552 864 250

nucleus@tbcardew.com

 

 

Further information

This announcement is for information purposes only and is not intended to and does not constitute, or form any part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities of Curtis Banks in any jurisdiction in contravention of applicable law. The Acquisition will be made and implemented solely pursuant to the terms of the Scheme Document (or if the Acquisition is implemented by way of a Takeover Offer, the Offer Document), which will contain the full terms and conditions of the Acquisition, including details of how to vote in respect of the Acquisition. Any vote in respect of, or other response to, the Acquisition should be made only on the basis of the information contained in the Scheme Document (or if the Acquisition is implemented by way of a Takeover Offer, the Offer Document).

This announcement does not constitute a prospectus, prospectus equivalent document or an exempted document.

The statements contained in this announcement are made as at the date of this announcement, unless some other times is specified in relation to them, and publication of this announcement shall not give rise to any implication that there has been no change in the facts set forth in this announcement since such date.

Disclaimer

Evercore Partners International LLP ("Evercore"), which is authorised and regulated by the Financial Conduct Authority in the UK, is acting exclusively as financial adviser to Nucleus and Bidco and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than Nucleus and Bidco for providing the protections afforded to clients of Evercore nor for providing advice in connection with the matters referred to herein. Neither Evercore nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Evercore in connection with this announcement, any statement contained herein, any offer or otherwise. Apart from the responsibilities and liabilities, if any, which may be imposed on Evercore by the Financial Services and Markets Act 2000 and successor legislation, or the regulatory regime established thereunder, or under the regulatory regime of any jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither Evercore nor any of its affiliates accepts any responsibility or liability whatsoever for the contents of this announcement, and no representation, express or implied, is made by it, or purported to be made on its behalf, in relation to the contents of this announcement, including its accuracy, completeness or verification of any other statement made or purported to be made by it, or on its behalf, in connection with Nucleus, Bidco or the matters described in this announcement. To the fullest extent permitted by applicable law, Evercore and its affiliates accordingly disclaim all and any responsibility or liability whether arising in tort, contract or otherwise (save as referred to above) which they might otherwise have in respect of this announcement or any statement contained herein.

Overseas jurisdictions

This announcement has been prepared in accordance with, and for the purposes of complying with, English law, the Takeover Code, the Market Abuse Regulation and the AIM Rules, and information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside of England.

The release, publication or distribution of this announcement in, into or from jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe any applicable requirements.

The availability of the Acquisition to Curtis Banks Shareholders who are not resident in and citizens of the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are located or of which they are citizen. Persons who are not resident in the United Kingdom should inform themselves of, and observe any applicable legal or regulatory requirements of their jurisdictions. In particular, the ability of persons who are not resident in the United Kingdom to vote their Curtis Banks Shares with respect to the Scheme at the Meetings, or to execute and deliver Forms of Proxy (or other proxy instructions) appointing another to vote at the Meetings on their behalf, may be affected by the laws of the relevant jurisdictions in which they are located. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person. Further details in relation to Overseas Shareholders are contained in the Scheme Document.

Unless otherwise determined by Bidco or required by the Takeover Code, and permitted by applicable law and regulation, the Acquisition will not be made available, in whole or in part, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction and no person may vote in favour of the Acquisition by any such use, means, instrumentality or from within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Copies of this announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send it in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Acquisition. If the Acquisition is implemented by way of a Takeover Offer (unless otherwise permitted by applicable law and regulation), the Takeover Offer may not be made directly or indirectly, in or into, or by the use of mails or any means or instrumentality (including, but not limited to, facsimile, e-mail or other electronic transmission, telex or telephone) of interstate or foreign commerce of, or of any facility of a national, state or other securities exchange of any Restricted Jurisdiction and the Takeover Offer may not be capable of acceptance by any such use, means, instrumentality or facilities.

The Acquisition will be subject to English law and the jurisdiction of the Court, and the applicable requirements of the Takeover Code, the Panel, the FCA, the London Stock Exchange (including pursuant to the AIM Rules) and the Registrar of Companies.

Notice to US investors in Curtis Banks

The Acquisition relates to the shares of an English company with a quotation on AIM and is being made by means of a scheme of arrangement provided for under English company law. A transaction effected by means of a scheme of arrangement is not subject to the tender offer rules or the proxy solicitation rules under the US Exchange Act of 1934. Accordingly, the Acquisition is subject to the disclosure requirements and practices applicable in the United Kingdom to schemes of arrangement which differ from the disclosure requirements of United States tender offer and proxy solicitation rules. Neither the United States Securities and Exchange Commission, nor any securities commission of any state of the United States, has approved or disapproved any offer, or passed comment upon the adequacy or completeness of any of the information contained in this announcement. Any representation to the contrary may be a criminal offence.

If, in the future, Bidco exercises the right, with the consent of the Panel (where necessary), to implement the Acquisition by way of a Takeover Offer and determines to extend the offer into the United States, the Acquisition will be made in compliance with applicable United States laws and regulations, including Section 14(e) of the US Securities Exchange Act 1934 and Regulation 14E thereunder.

Financial information included in this announcement and the Scheme Document (or, if the Acquisition is implemented by way of a Takeover Offer, the Offer Document) has been or will have been prepared in accordance with accounting standards applicable in the United Kingdom that may not be comparable to financial information of US companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the United States.

The receipt of cash pursuant to the Acquisition by a US holder of Curtis Banks Shares as consideration for the transfer of its Scheme Shares pursuant to the Scheme may be a taxable transaction for US federal income tax purposes and under applicable US state and local, as well as foreign and other, tax laws. Each Curtis Banks Shareholder is therefore urged to consult with independent legal, tax and financial advisers in connection with making a decision regarding the Acquisition.

It may be difficult for US holders of Curtis Banks Shares to enforce their rights and any claim arising out of the US federal laws in connection with the Acquisition, since Bidco and Curtis Banks are located in, and organised under the laws of, a non-US jurisdiction, and some or all of their officers and directors may be residents of a non-US jurisdiction. US holders of Curtis Banks Shares may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's jurisdiction or judgement.

In accordance with normal UK practice and pursuant to Rule 14e-5(b) of the US Securities Exchange Act of 1934, Bidco, certain affiliated companies and their nominees or brokers (acting as agents), may from time to time make certain purchases of, or arrangements to purchase, Curtis Banks Shares outside of the US, other than pursuant to the Acquisition, until the date on which the Acquisition and/or Scheme becomes Effective, lapses or is otherwise withdrawn. Also, in accordance with Rule 14e-5(b) of the US Securities Exchange Act of 1934, each of Evercore, Fenchurch, Peel Hunt and Singer Capital Markets Securities will continue to act as an exempt principal trader in Curtis Banks Shares on the London Stock Exchange. If such purchases or arrangements to purchase were to be made, they would occur either in the open market at prevailing prices or in private transactions at negotiated prices and comply with applicable law, including the US Securities Exchange Act of 1934. Any information about such purchases will be disclosed as required in the UK, will be reported to the Regulatory News Service of the London Stock Exchange and will be available on the London Stock Exchange website at www.londonstockexchange.com.

Dealing and Opening Position Disclosure Requirements

Under Rule 8.3(a) of the Takeover Code, any person who is interested in one per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the Offer Period and, if later, following the announcement in which any securities exchange offeror is first identified.

An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the Offer Period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the Offer Period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Publication on a website

In accordance with Rule 26.1 of the Takeover Code, a copy of this announcement will be made available, subject to certain restrictions relating to persons resident in restricted jurisdictions, on Nucleus' website at www.nucleusfinancialplatforms.com no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to above is not incorporated into and does not form part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPTPMMTMTBTTLJ
Date   Source Headline
3rd May 20242:03 pmRNSNet Asset Value(s)
2nd May 20242:17 pmRNSNet Asset Value(s)
1st May 20243:05 pmRNSNet Asset Value(s)
1st May 202410:11 amRNSTotal Voting Rights
30th Apr 20243:20 pmRNSNet Asset Value(s)
29th Apr 20241:25 pmRNSNet Asset Value(s)
26th Apr 20245:44 pmRNSIssue of Equity
26th Apr 20242:22 pmRNSNet Asset Value(s)
25th Apr 20244:39 pmRNSNet Asset Value(s)
24th Apr 20241:34 pmRNSNet Asset Value(s)
23rd Apr 20242:28 pmRNSNet Asset Value(s)
22nd Apr 20242:00 pmRNSNet Asset Value(s)
19th Apr 202412:57 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
18th Apr 20243:23 pmRNSNet Asset Value(s)
17th Apr 20242:23 pmRNSNet Asset Value(s)
16th Apr 20242:48 pmRNSNet Asset Value(s)
15th Apr 20242:04 pmRNSNet Asset Value(s)
12th Apr 20242:44 pmRNSNet Asset Value(s)
11th Apr 20244:02 pmRNSMonthly Fact Sheet as at 31 March 2024
11th Apr 20242:44 pmRNSNet Asset Value(s)
10th Apr 20243:10 pmRNSNet Asset Value(s)
10th Apr 20242:52 pmRNSDirector/PDMR Shareholding
9th Apr 20242:57 pmRNSNet Asset Value(s)
8th Apr 20244:20 pmRNSIssue of Equity
8th Apr 20241:45 pmRNSNet Asset Value(s)
5th Apr 20242:37 pmRNSNet Asset Value(s)
4th Apr 20242:31 pmRNSNet Asset Value(s)
3rd Apr 20243:44 pmRNSNet Asset Value(s)
2nd Apr 20244:20 pmRNSNet Asset Value(s)
2nd Apr 202410:23 amRNSTotal Voting Rights
2nd Apr 20249:54 amRNSDirectorate Change
28th Mar 20245:57 pmRNSDirector/PDMR Shareholding
28th Mar 20241:51 pmRNSNet Asset Value(s)
27th Mar 20241:20 pmRNSNet Asset Value(s)
26th Mar 20243:34 pmRNSNet Asset Value(s)
25th Mar 20242:23 pmRNSNet Asset Value(s)
25th Mar 202410:32 amRNSDirector/PDMR Shareholding
22nd Mar 20241:54 pmRNSNet Asset Value(s)
21st Mar 20241:26 pmRNSNet Asset Value(s)
20th Mar 20245:09 pmRNSIssue of Equity
20th Mar 20241:10 pmRNSNet Asset Value(s)
19th Mar 20242:48 pmRNSNet Asset Value(s)
18th Mar 20244:34 pmRNSIssue of Equity
18th Mar 20243:09 pmRNSNet Asset Value(s)
15th Mar 20241:52 pmRNSNet Asset Value(s)
14th Mar 20241:53 pmRNSNet Asset Value(s)
13th Mar 20245:02 pmRNSIssue of Equity
13th Mar 20241:39 pmRNSNet Asset Value(s)
12th Mar 20244:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.